Global longitudinal strain as an early marker of cardiac damage after cardiotoxic medications, a state-of-the-art review
Authors:
Open Access
- 9 January 2025
- journal article
- review article
- Published by Elsevier in Progress in Cardiovascular Diseases
- Vol. 89, 92-101
Abstract
No abstract availableKeywords
This publication has 98 references indexed in Scilit:
- Global longitudinal strain at 3 months after therapy can predict late cardiotoxicity in breast cancerCancer Medicine, 2023
- Cardiotoxicity screening of long‐term, breast cancer survivors—The CAROLE (Cardiac‐Related Oncologic Late Effects) StudyCancer Medicine, 2021
- Adjuvant Breast Cancer Treatments Cardiotoxicity and Modern Methods of Detection and Prevention of Cardiac ComplicationsESC Heart Failure, 2021
- Speckle-Tracking Echocardiography for Cardioncological Evaluation in Bevacizumab-Treated Colorectal Cancer PatientsCardiovascular Toxicology, 2020
- Assessment of Prognostic Value of Left Ventricular Global Longitudinal Strain for Early Prediction of Chemotherapy-Induced CardiotoxicityJAMA Cardiology, 2019
- Evaluation of Cardiovascular Toxicity Associated with Treatments Containing Proteasome Inhibitors in Multiple Myeloma TherapyHigh Blood Pressure & Cardiovascular Prevention, 2018
- Abnormal Myocardial Strain Indices in Children Receiving Anthracycline ChemotherapyPediatric Cardiology, 2015
- Antiviral treatment for hepatitis C virus infection is associated with improved renal and cardiovascular outcomes in diabetic patientsHepatology, 2014
- Trastuzumab‐associated cardiotoxicityCancer, 2002
- Clinical trials with adriamycinCancer, 1971